CIRECA

Owners

Goods & Services

Cloud computing for pathology and whole slide imaging featuring software for use in automated acquisition and analysis of images of human and animal cells and tissues, for use in entering, storing and analyzing data, for management of medical diagnostic, prognostic and predictive information by clinicians, research scientists and pathologists and other laboratory professionals in the fields of pathology, oncology, pharmaceutical drug and therapy development and whole slide imaging, data reporting, tissue bank sample management and test results archiving, with data archiving and retrieval features; providing databases in the field of spectral imaging information based on biomarkers for disease detection and treatment for scientific research purposes; providing an on-line searchable database in the field of pathology and the use of biomarkers for disease detection and treatment for scientific research purposes only; clinical laboratory providing biomarker research services; data mining of database featuring patient sample biomarkers; biomarker screening for scientific research purposes; pharmaceutical drug design; pharmaceutical research and development services in the fields of drug design and drug delivery; conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical research and development in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; custom design and development of companion diagnostic tests and assays in the field of gene therapy design and delivery; and laboratory services, namely, archiving tissue and cell samples for use in the field of gene therapy design and delivery for research purposes

Providing on-line searchable databases featuring health-related information on spectral results of biomarkers used in the detection and treatment of disease; medical diagnostic, prognostic and predictive reporting services; medical services in the fields of cytology, histology and pathology; medical adjunctive and triage testing for diagnostic and treatment purposes; medical prognostic and diagnostic testing in the field of biomarkers for disease detection and treatment; medical screening, medical monitoring, and medical companion diagnostic testing services; medical services, namely, gene therapy design and delivery services in the fields of oncology, pathology, and biomarkers